Behavioral Parenting Skills as a Novel Target for Improving Pediatric Medication Adherence: Study 3

Launched by ROSWELL PARK CANCER INSTITUTE · Oct 3, 2023

Keywords

ClinConnect Summary

This clinical trial, titled "Behavioral Parenting Skills as a Novel Target for Improving Pediatric Medication Adherence," is looking at a new way to help parents ensure their children take their cancer medication regularly. The study will involve 100 families with children aged 3 to 9 who are being treated for Acute Lymphoblastic Leukemia (ALL) in Buffalo, NY, and Atlanta, GA. The goal is to see if a program called CareMeds is acceptable and practical for families to use.

To be eligible for this study, a parent must be responsible for giving their child the medication and be fluent in English or Spanish. Their child should be currently receiving treatment that includes oral medications taken at home, like 6-MP. If you decide to participate, you will be asked to sign a consent form and follow some guidelines throughout the study. This research aims to support families in managing their children's treatment better, which can be crucial for their health and recovery.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Parent of a child who is diagnosed and being treated for any type of acute lymphoblastic leukemia (ALL) at a study site.
• • Parent has primary medication responsibility.
• • Pediatric patient aged 3-9 years
• • Child on therapy that includes home-based oral anti-cancer medication taken at home, such as 6-MP.
• • Parent has verbal English or Spanish fluency.
• • Participant must understand the investigational nature of this study and sign an Independent Ethics Committee/Institutional Review Board approved written informed consent form prior to receiving any study related procedure
• Exclusion Criteria:
• • Parent of a child who is not diagnosed nor being treated for any type of acute lymphoblastic leukemia (ALL) at a study site.
• • Parent does not have primary medication responsibility.
• • Pediatric patient aged 3-9 years
• • Pediatric patient is not on therapy that includes oral anti-cancer medication (e.g., 6-MP).
• • Parent does not have verbal English or Spanish fluency.
• • Parent is unwilling or unable to follow protocol requirements